Alector (ALEC) Free Cash Flow (2018 - 2026)
Alector (ALEC) reported Free Cash Flow of -$49.9 million for Q1 2026, up 17.85% year-over-year from -$42.4 million in Q1 2025, and down 19.65% quarter-over-quarter from -$41.7 million in Q4 2025.
Alector (ALEC) Free Cash Flow (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Free Cash Flow data on file, last reported at -$49.9 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$49.9 million, up 17.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$173.2 million (up 24.71% YoY), and the FY2025 annual result was -$184.1 million, up 20.37% from the prior year.
- Free Cash Flow retreated to -$49.9 million in Q1 2026 per ALEC's latest filing, from -$41.7 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $134.6 million in Q1 2022 and troughed at -$62.4 million in Q2 2024.
- A 5-year average of -$39.6 million and a median of -$49.7 million in 2022 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2023: Free Cash Flow soared 352.42% in 2022, then plunged 136.3% in 2023.
- A 5-year view of Free Cash Flow shows it stood at -$49.7 million in 2022, then grew by 11.26% to -$44.1 million in 2023, then declined by 25.19% to -$55.2 million in 2024, then grew by 24.4% to -$41.7 million in 2025, then dropped by 19.65% to -$49.9 million in 2026.
- Business Quant data shows ALEC's Free Cash Flow at -$49.9 million in Q1 2026, -$41.7 million in Q4 2025, and -$32.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -49.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.93 Mn |
| Mar 31, 2026 | -49.93 Mn |
| Dec 31, 2025 | -41.73 Mn |
| Dec 31, 2025 | -41.73 Mn |
| Sep 30, 2025 | -32.48 Mn |
| Sep 30, 2025 | -32.48 Mn |
| Jun 30, 2025 | -49.08 Mn |
| Jun 30, 2025 | -49.08 Mn |
| Mar 31, 2025 | -60.78 Mn |
| Mar 31, 2025 | -60.78 Mn |
| Dec 31, 2024 | -55.20 Mn |
| Dec 31, 2024 | -55.20 Mn |
| Sep 30, 2024 | -51.63 Mn |
| Sep 30, 2024 | -51.63 Mn |
| Jun 30, 2024 | -62.45 Mn |
| Jun 30, 2024 | -62.45 Mn |
| Mar 31, 2024 | -61.88 Mn |
| Mar 31, 2024 | -61.88 Mn |
| Dec 31, 2023 | -44.09 Mn |
| Dec 31, 2023 | -44.09 Mn |